Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Miguel Ángel Canales"'
Autor:
Agnes Nagy, Rene-Olivier Casasnovas, Sameer Bakhshi, Sharon Shacham, Juan-Manuel Sancho, Ronit Gurion, Josée M. Zijlstra, Jatin P. Shah, Miklos Egyed, Brian T. Hill, Krzysztof Warzocha, Gabriel Tremblay, Michael W. Schuster, Fritz Offner, Reda Bouabdallah, Dimitrios Tomaras, Paolo Caimi, Andre Goy, Priyanka Samal, Catherine Thieblemont, Joost S.P. Vermaat, Matthew Ku, Ulrich Jäger, John Kuruvilla, Nagesh Kalakonda, George A Follows, Eric Van Den Neste, Miguel Ángel Canales Albendea, Michael Kauffman, Nada Hamad, Fatima De la Cruz, Patrick Daniele, Marie Maerevoet, Theodoros Vasilakopoulos, Federica Cavallo, Sylvain Choquet
Publikováno v:
Future Oncology
Future Oncology, Future Medicine, 2021, 17 (11), pp.1295-1310. ⟨10.2217/fon-2020-0946⟩
Future Oncology, 17(11), 1295-1310. FUTURE MEDICINE LTD
FUTURE ONCOLOGY
Future oncology, Vol. 17, no.11, p. 1295-1310 (2021)
Future Oncology, Future Medicine, 2021, 17 (11), pp.1295-1310. ⟨10.2217/fon-2020-0946⟩
Future Oncology, 17(11), 1295-1310. FUTURE MEDICINE LTD
FUTURE ONCOLOGY
Future oncology, Vol. 17, no.11, p. 1295-1310 (2021)
Aim: Evaluate health-related quality of life (HRQoL) and health utility impact of single-agent selinexor in heavily pretreated patients with relapsed/refractory diffuse large B-cell lymphoma. Patients & methods: Functional Assessment of Cancer Therap
Autor:
Eduardo García Pérez, Raquel de Paz Arias, Beatriz de la Cruz Benito, Patricia Baltasar Tello, Abel Dos Santos Ortas, Victor Jiménez Yuste, Irene Sánchez Vadillo, Andres Lopez, Ana López de la Guía, Karem Humala Barbier, Paula Lázaro del Campo, Mercedes Gasior Kabat, Teresa de Soto Álvarez, Miguel Ángel Canales Albendea
Publikováno v:
Expert Review of Hematology
Spain is one of the countries most strongly affected by the coronavirus (COVID-19) pandemic with more than 800,000 cases reported in the country as of October 5 [1]. In Madrid, the first reported c...
Autor:
Abel Dos Santos-Ortas, Ana López de la Guía, Víctor Jiménez-Yuste, Miguel Ángel Canales-Albendea, Teresa de Soto-Álvarez, Andrés Ramírez-López, Irene Sánchez-Vadillo, Gema Casado-Abad, Paula Lázaro del Campo, Karem Humala-Barbier, Eduardo García-Pérez, Beatriz de la Cruz-Benito
Publikováno v:
British Journal of Haematology
The COVID‐19 pandemic has dramatically challenged care for cancer patients, especially those with active treatment that represent a vulnerable population for SARS‐CoV‐2 infection. Aggressive lymphoid neoplasms, such as diffuse large B‐cell ly
Autor:
Armando, López-Guillermo, Miguel Ángel, Canales, Ivan, Dlouhy, Santiago, Mercadal, Javier, Briones, Alejandro, Martín García-Sancho, Juan Manuel, Sancho, José María, Moraleda, María José, Terol, Antonio, Salar, Luis, Palomera, Santiago, Gardella, Isidro, Jarque, Secundino, Ferrer, Joan, Bargay, Andrés, López, Carlos, Panizo, Anna, Muntañola, Carlos, Montalbán, Eulogio, Conde, Miguel T, Hernández, Alfons, Soler, José A, García Marco, Guillermo, Deben, Julián, Marín, José Francisco, Tomás
Publikováno v:
Leukemialymphoma. 63(1)
This is a randomized phase-2 trial aimed to compare consolidation vs. maintenance in untreated patients with follicular lymphoma (FL) responding to induction. 146 patients were enrolled from 25 Spanish institutions (ZAR2007; ClinicalTrials.gov #NCT00
Publikováno v:
Revista de Aplicaciones del Derecho. :7-20
Currently, a new company is claimed that includes the principles of sustainability and results in its actions, generating satisfaction for all stakeholders. Corporate social responsibility (CSR) seeks to create a balance between economic benefits and
Autor:
Alejandro Morales-Ortega, Beatriz Jaenes-Barrios, Miguel Ángel Canales-Albendea, Jaime García de Tena, Ana Isabel Farfán-Sedano, Begoña Frutos-Pérez, David Bernal-Bello
Publikováno v:
Cancer
Autor:
Sunny Pokala, Ekaterina Vorozheikina, Thomas A. Buchholz, Laura Fogliatto, Dirk Klingbiel, Takayuki Ishikawa, Monique S Tomiczek, Joana Parreira, Kai Hübel, Miguel Ángel Canales Albendea, Koji Izutsu
Publikováno v:
Journal of Clinical Oncology. 39:7545-7545
7545 Background: Obinutuzumab (G)-chemotherapy (chemo) has demonstrated improved progression-free survival compared with rituximab (R)-chemo in previously untreated advanced follicular lymphoma (FL). G is currently administered by IV infusion over ̃
Autor:
Miguel Ángel Canales Albendea, Valeria Marongiu, Rocío Rodríguez Rey, Javier Barbero Gutiérrez, Mirian Prado Redondo, Rafael Selgas Gutiérrez, Helena García-Llana
Publikováno v:
Medicina Paliativa. 21:98-104
Resumen Objetivos Evaluar el impacto emocional y la utilidad percibida de las cartas de condolencia en familiares de pacientes fallecidos en los servicios de nefrologia y hematologia. Metodo Estudio prospectivo con una unica medida en forma de entrev
Autor:
Miguel Ángel Canales Albendea, Luis Lombardia, Ana Esther Kerguelen Fuentes, Ana Rodríguez de la Rúa, Dolores Hernández-Maraver
Publikováno v:
Medicina Clínica. 139:373-378
Resumen Fundamento y objetivo La identificacion de la mutacion V617F del gen JAK2 en pacientes diagnosticados de neoplasias mieloproliferativas cronicas (NMPC) es fundamental en el cribado diagnostico. Nuestro objetivo fue investigar la asociacion en
Publikováno v:
Anales de Pediatría Continuada. 7:24-28